USV Private Limited has emphasised that small changes in pharmaceutical packaging can have a significant impact on patient adherence to medication. While the primary role of packaging is to protect medicines from external damage, USV notes its equally vital function in promoting consistent and accurate medication intake, especially for chronic illness management.

In a recent study conducted by USV on 844 individuals across metros, Tier I, and Tier II cities, the findings revealed that 82.9% of elderly patients (over 60) identified their medications by strip or pack colour, while 25.6% relied on tablet or capsule colour. In metro cities, 35.1% admitted to frequently forgetting doses—a problem that can be alleviated through brightly coloured blister packs, distinct shapes, and clear labelling. Such visual aids make medicines more recognisable, support routine building, and assist with on-time consumption.

The research also found that well-designed packaging significantly reduces dispensing errors, ensuring better safety for patients and accuracy among pharmacists—particularly important in the treatment of chronic diseases such as diabetes and hypertension.

According to Dr Rajiv Karnik, Consultant Cardiologist, Mumbai, “Improving medication adherence promotes long-term compliance, better health outcomes, and reduced complications. This, in turn, eases the burden on healthcare systems and allows more focus on urgent care needs.”

The World Health Organization (WHO) defines adherence as essential for successful treatment outcomes. Non-adherence, often worsened by poor packaging, can result in increased hospitalisations and financial strain. While technological solutions like smart pill dispensers exist, they are not accessible to everyone. This makes effective, patient-friendly packaging a powerful and inclusive tool.

USV advocates for the Patient-Centric Pharmaceutical Drug Product Design (PCPDPD) strategy, which prioritises the design, dosing, and packaging needs of the patient. By embracing PCPDPD principles, pharmaceutical companies can strengthen their commitment to patient centricity and improve adherence through innovative packaging design.